Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.23.B14 extracted from

  • Andrews, K.T.; Fairlie, D.P.; Madala, P.K.; Ray, J.; Wyatt, D.M.; Hilton, P.M.; Melville, L.A.; Beattie, L.; Gardiner, D.L.; Reid, R.C.; Stoermer, M.J.; Skinner-Adams, T.; Berry, C.; McCarthy, J.S.
    Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria (2006), Antimicrob. Agents Chemother., 50, 639-648.
    View publication on PubMedView publication on EuropePMC

Inhibitors

Inhibitors Comment Organism Structure
pepstatin IC50: about 1 nM Plasmodium falciparum
ritonavir IC50: 1800 nM Plasmodium falciparum
saquinavir IC50: 375 nM Plasmodium falciparum

Organism

Organism UniProt Comment Textmining
Plasmodium falciparum
-
-
-

Synonyms

Synonyms Comment Organism
PM-IV
-
Plasmodium falciparum

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.000001
-
IC50: about 1 nM Plasmodium falciparum pepstatin
0.000375
-
IC50: 375 nM Plasmodium falciparum saquinavir
0.0018
-
IC50: 1800 nM Plasmodium falciparum ritonavir